Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > SBM mgmt, get on with it
View:
Comment by biorun on Jun 01, 2023 9:22pm
The shelves are full with products that don't work well and yet still find oddly remarkable growth channels. I have tried many and the women around me say the exact same thing. We should all be looking forward to market introduction of the TFC 1067 dyschromia treatment, and we finally get our payday with AbbVie. The question I have is how global it gets and what share of product sales can ...more  
Comment by navajojoe on Jun 02, 2023 8:29am
Considering we gave Abbvie a GLOBAL and EXCLUSIVE licence for TFC-1067, and not JUST for TFC-1067 but some related products that come from certain patents, we darn well better get something significant in the form of CASH. If this turns out to be another R&F joke, the next annual meeting won't be pleasant for management. And we are coming up on the 1-year anniversary of the Abbvie ...more  
Comment by Pareto8020 on Jun 02, 2023 9:06am
Hard to believe it has been a year since they signed the Abbie deal.  And what updates have been provided since the deal was signed?  Zero zip zilch.  Typical SBM protocol - talk talk talk then when actual details are needed they go radio silent and will start pointing to the next shiny object with hopes shareholders will be distracted by that. You would think a milestone of some ...more  
Comment by navajojoe on Jun 02, 2023 12:17pm
Every time Howie signs another one of these go-nowhere deals, it makes one wonder just what the heck he is doing, other than cashing a paycheck.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities